Clinical Trials in China / NCT06753734
Enrolling by invitation
Observational
Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
NCT06753734 · tracked via the Priya Life Science China tracker
Condition(s) studied
Gestational Diabetes
Study summary
This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.
Eligibility
Eligibility Criteria
* 18-55 years old
* 11-14 weeks of pregnancy
* at least one risk factor for GDM
* signed a written informed consent
Exclusion Criteria:
* Diabetes mellitus or abnormal glucose metabolism before pregnancy
* Hyperemesis gravidarum (urine ketone positive))
* Thyroid dysfunction
* Asthmatic patients
* Hypertensive diseases that are difficult to control
* Severe hepatic and renal insufficiency or severe electrolyte disturbance
* Malignant tumor
* Acute inflammation
* lung disease
* Patients with gastritis, duodenum and other digestive system diseases
* Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
* smoker
Primary outcome measure(s)
- Incidence of gestational diabetes mellitus — 24-28 weeks gestation
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tianjin Central Hospital of Gynecology Obstetrics | Tianjin | China |
More Tianjin Central Hospital of Gynecology Obstetrics trials in China
Other trials for the same condition
Shenzhen Birth Cohort Study
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06753734 on ClinicalTrials.gov ↗ ← All trials in China